Search - Prime Therapeutics
388 Results for GLP-1 Pipeline Update
-
publications High-Cost Therapy Profile: March 2025 Pegzilarginase Intravenous (IV), Subcutaneous (SC) | Immedica Metabolic March 14, 2025 Proposed indications Arginase 1 deficiency (ARG1-D)...
-
Get the most value and best outcomes from C> Cell and gene therapies (C>s) represent breakthrough science, but often come at a high cost. Breadcrumb Home Our solutions Condition management Cell...
-
Breadcrumb Home Newsroom Custom Content Publications Drug Approvals Monthly Update: September 2024 PUBLICATIONS Drug Approvals Monthly Update: September 2024 This monthly update of United States...
-
Biobetters are just a nickname; they’re based on existing biologics but with a few key differences
PA Sub-Categories: Specialty drugs Prime Article: Perspectives
Compliance / Legal
© 2025 Prime Therapeutics LLC